Treatment of plasma cell leukemia in patients under 70 years [Traitement des leucémies primitives à plasmocytes du sujets de moins de 70 ans]

Trial Profile

Treatment of plasma cell leukemia in patients under 70 years [Traitement des leucémies primitives à plasmocytes du sujets de moins de 70 ans]

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Apr 2016

At a glance

  • Drugs Bortezomib (Primary) ; Doxorubicin liposomal (Primary) ; Lenalidomide (Primary)
  • Indications Plasma cell leukaemia
  • Focus Therapeutic Use
  • Acronyms AOL09-DrROYER
  • Most Recent Events

    • 25 Apr 2016 Status changed from active, no longer recruiting to completed according to results published in the Journal of Clinical Oncology.
    • 25 Apr 2016 Results published in the Journal of Clinical Oncology
    • 01 Jul 2013 Status changed from recruiting to active, no longer recruiting according to results published in the Journal of Clinical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top